Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Urine Exfoliated Cell DNA Methylation Detection for Urothelial Carcinomas Diagnosis in Patients With Hematuria--A Prospective, Single-center, Cohort Study

NCT06427993 is registered in ClinicalTrials.gov with Changhai Hospital as lead sponsor.

NCT NCT06427993
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06427993 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Urine Exfoliated Cell DNA Methylation Detection for Urothelial Carcinomas Diagnosis in Patients With Hematuria--A Prospective, Single-center, Cohort Study
Lead sponsor
Changhai Hospital
Phase
Observational
Overall status
Unknown status
Start date
June 15, 2024
Completion date
December 31, 2025
Enrollment
71 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, hematuria, renal pelvis cancer, ureter cancer, urothelial carcinoma